Real|World Treatment Patterns and Patient Outcomes in Relapsed ...

Real-world treatment patterns and outcomes in relapsed/refractory ...

In 561 patients with 1 prior LOT at inclusion, the cumulative attrition rate from LOT 2 to 5 was 85%, which included 25% patients who died and ...

Real-World Treatment Patterns and Patient Outcomes in Relapsed ...

In this study, we investigated the real-world treatment patterns and outcomes of patients with relapsed/refractory HL (RRHL) who had received ≥1 line of ...

Real-world treatment patterns and outcomes in relapsed/refractory ...

In the context of multiple myeloma (MM), early use of the immunomodulatory drug lenalidomide has led to an increased population of patients ...

Recent real-world treatment patterns and outcomes in US ... - PubMed

Background: In patients with relapsed/refractory multiple myeloma (RRMM) previously receiving 1-3 therapy lines, newer agents demonstrated ...

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN ...

However, approval and access to new treatments may be delayed, potentially impacting patient (pt) outcomes. This study assessed real-world (RW) treatment ...

Recent real-world treatment patterns and outcomes in US patients ...

In patients with relapsed/refractory multiple myeloma (RRMM) previously receiving 1–3 therapy lines, newer agents demonstrated improved outcomes versus older ...

Current real-world treatment patterns and outcomes in patients with ...

Background: Limited real-world data exist on treatments for relapsed/refractory multiple myeloma (RRMM) since the recent approval of new agents.

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN ...

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WITH AT LEAST ONE PRIOR THERAPY IN BRAZIL · Objectives · Material ...

Real‐World Treatment Patterns, Outcomes, and Healthcare ...

From first relapse, patients were assessed on second-/third-line treatments, progression-free survival (PFS), overall survival (OS), and ...

Assessment of real-world treatment patterns and outcomes in ...

The survey collected physicians' opinions on typical treatment patterns and outcomes of RRMM patients in the relapse/refractory setting (following disease ...

REAL-WORLD (RW) TREATMENT PATTERNS AND OUTCOMES IN ...

Data on RW treatment patterns and outcomes in RRMM Pts who received at least one prior line of therapy (LoT) are lacking outside the US and Europe. This study ...

KarMMa-RW: A study of real-world treatment patterns in heavily ...

KarMMa-RW: A study of real-world treatment patterns in heavily pretreated patients with relapsed and refractory multiple myeloma (RRMM) and ...

Real-world treatment patterns in relapsed/refractory multiple myeloma

Real-world treatment patterns in relapsed/refractory multiple myeloma: Clinical and economic outcomes in patients treated with pomalidomide or daratumumab.

Treatment Patterns and Patient Outcomes in Relapsed/Refractory ...

... treatments in real-world practice, but remains limited due to the rapid evolution of MM treatments and associated outcomes. Objective. To ...

results from the international SCHOLAR-5 study | Haematologica

The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular lymphoma (FL) patients on 3rd line of treatment (LoT) or higher, for whom ...

p899: real-world assessment of treatment patterns and outcomes in ...

Summary/Conclusion: PI-exposed, lenalidomide-refractory patients with 1-3 PL were treated with various regimens. These patients have poor OS and progress ...

Refractory Multiple Myeloma with At Least Two Prior Therapies in ...

Real-World Treatment Patterns and Outcomes in Patients with Relapsed/ ... Patient characteristics and treatment patterns were summarized ...

3242 Real-World Treatment Patterns and Outcomes of Proteasome ...

3242 Real-World Treatment Patterns and Outcomes of Proteasome ... Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Engaged in Routine ...

Recent real-world treatment patterns and outcomes in US patients ...

Evaluation of new treatments on patient outcomes will influence treatment patterns and patient outcomes in the real-world setting. Conclusions ...

Treatment patterns and outcomes according to cytogenetic risk ...

We utilized real-world data from a US database to examine treatment patterns and outcomes in patients by t(11;14) status compared with high- and standard-risk ...